CD-19 mutation frequency after blinatumomab treatment is lower than after CAR T-cell therapy

Controlling CRS-related coagulopathy improves the safety of CAR T-cell therapy for MM

ICARIA results: Treating RRMM patients with isatuximab, pomalidomide and low-dose dexamethasone

HORIZON update: Using melflufen to treat RRMM patients refractory to daratumumab and/or pomalidomide

CD33 T cell recruiting antibody constructs for treatment of relapsed refractory AML

Targeted treatment of AML using T cell recruiting antibody constructs

Cancer care in low and middle income countries

Surveying cancer patients' mental health and financial problems

Implementing better cancer diagnosis in low and middle income countries

Use of maintenance therapy following ASCT and real world treatment patterns in multiple myeloma

Most pregnancies in CML patients resulted in normal childbirth: Analysis of 305 cases of the European Leukemia Net registry

Comment: Chemotherapy for frail and elderly patients with advanced gastroesophageal cancer